Literature DB >> 24083993

Proliferative phenotype of pulmonary microvascular endothelial cells plays a critical role in the overexpression of CTGF in the bleomycin-injured rat.

Lin-Feng Yan1, Ya-Ning Wei, Hai-Yan Nan, Qian Yin, Yue Qin, Xin Zhao, Bao-Ying Chen, Ge Zhao, Jing-Guo Wei, Guang-Bin Cui.   

Abstract

The pathogenesis of idiopathic pulmonary fibrosis (IPF) is not very clear, with evidence for the involvement of both inflammation and aberrant vascular remodeling (associated with angiogenesis). Pulmonary microvascular endothelial cells (PMVECs), which play a major role in inflammation, secrete cytokines that promote the transformation and collagen synthesis of fibroblasts. Moreover, angiogenesis is characterized by PMVEC proliferation. The main aim of this study was to confirm the role of PMVECs in pulmonary fibrosis. Accordingly, we observed the functional changes in PMVECs in bleomycin (BLM)-treated rats (pulmonary fibrosis model) in vivo, and compared them with those of rats with pneumonia. The proliferation phenotype and intracellular ionized calcium concentration ([Ca(2+)]i) of PMVECs from BLM-treated rats were also investigated. The functioning of PMVECs was abnormal in BLM-injured rats, particularly with regard to their proliferation and secretion of connective tissue growth factor (CTGF). [Ca(2+)]i was increased in the proliferated PMVECs from BLM-treated rats. The findings suggest that dysfunction of PMVECs characterized by overexpression of CTGF is critical in rat pulmonary injury induced by BLM, and is probably related with the proliferative phenotype and [Ca(2+)]i overload. It can be concluded from the results that proliferation of PMVECs plays an important role in the pathogenesis of BLM-induced PF.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Aberrant vascular remodeling; Bleomycin; Inflammation; Proliferative endothelial cells; Pulmonary fibrosis

Mesh:

Substances:

Year:  2013        PMID: 24083993     DOI: 10.1016/j.etp.2013.08.004

Source DB:  PubMed          Journal:  Exp Toxicol Pathol        ISSN: 0940-2993


  4 in total

1.  Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis.

Authors:  Shinpei Kato; Naoki Inui; Akio Hakamata; Yuzo Suzuki; Noriyuki Enomoto; Tomoyuki Fujisawa; Yutaro Nakamura; Hiroshi Watanabe; Takafumi Suda
Journal:  Respir Res       Date:  2018-06-26

Review 2.  CCN2 (Cellular Communication Network factor 2) in the bone marrow microenvironment, normal and malignant hematopoiesis.

Authors:  Roos J Leguit; Reinier A P Raymakers; Konnie M Hebeda; Roel Goldschmeding
Journal:  J Cell Commun Signal       Date:  2021-01-11       Impact factor: 5.782

3.  Genetic Variation in the Platelet Endothelial Aggregation Receptor 1 Gene Results in Endothelial Dysfunction.

Authors:  Adam S Fisch; Laura M Yerges-Armstrong; Joshua D Backman; Hong Wang; Patrick Donnelly; Kathleen A Ryan; Ankita Parihar; Mary A Pavlovich; Braxton D Mitchell; Jeffrey R O'Connell; William Herzog; Christopher R Harman; Jonathan D Wren; Joshua P Lewis
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

4.  The Mammalian Target of Rapamycin and DNA methyltransferase 1 axis mediates vascular endothelial dysfunction in response to disturbed flow.

Authors:  Yun-Peng Zhang; Yi-Tao Huang; Tse-Shun Huang; Wei Pang; Juan-Juan Zhu; Yue-Feng Liu; Run-Ze Tang; Chuan-Rong Zhao; Wei-Juan Yao; Yi-Shuan Li; Shu Chien; Jing Zhou
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.